SlideShare a Scribd company logo
1 of 15
Perceived Barriers to Smoking Cessation
Mediates Tobacco Dependence and
Withdrawal in a Primarily African
American Sample
Anika Suddath & Thomas Rutner
Department of Preventive Medicine, USC
1
Tobacco Related Race Disparities
African Americans are affected disproportionately
American Lung Association, 2010
Figure from NHIS data
2
Dependence and Withdrawal
• More heavily dependent smokers experience more
severe withdrawal symptoms
• Withdrawal Symptoms
– anger, anxiety, craving, difficulty concentrating,
hunger, impatience, and restlessness
Shiffman (1989) Psycho Pharm
Hughes et al., (1991) Arch Gen Psychiatry
3
Withdrawal and Cessation Success
• Severe withdrawal symptoms cause poorer cessation
success rates
• Previous cognitive mechanisms
– Depression
– Anxiety
Patten and Martin (1996) Ann Behav Med
4
Perceived Barriers
Internal: “feeling less in control of your moods”
External: “no encouragement or help from friends”
Addiction: “thinking of never being able to smoke again”
Perceived barriers predict smoking cessation rates
Macnee & Talsma (1995)
Nursing Research
5
Hypothesis
Perceived barriers to cessation act as a cognitive
pathway to mediate the relationship between
dependence and acute tobacco withdrawal
Dependence Barriers Withdrawal
6
Participants
249 daily smokers
• non-treatment seeking
• > 10 cig/day for past 2
years
• no use of non-cigarette
tobacco or nicotine
products
Age (SD) 47.2 (11.1)
Sex 45.6% Female
Race 90.4% African American
Cigs/day 14.9 (6.6)
Years
Smoked
27.8 (12.1)
Quit
Attempts
4.6 (9.8)
7
Procedure
Baseline Session
Deprived
Non-Deprived
8
Experimental
Sessions
Measures
Baseline Session
• Fagerström Test of Nicotine Dependence (FTND)
• Barriers to Cessation Scale (BCS)
– Internal, External, & Addiction Subscales
Experimental Sessions
• Minnesota Nicotine Withdrawal Scale (MNWS)
Hughes & Hatsukami,
(1986) Gen Psychiatry
Heatherton et al., (1991) Brit Jour Addict;
Macnee & Talsma, (1995) Nurse
Research; 9
Statistical Analysis
BCS Subscale
Direct Effect
A Path B Path
Indirect Effect: A × B
FTND MNWS
10
Hayes, (2012)
BCS Addiction Mediational Pathway
BCS Addiction
ß=0.18 (.06, .29)
ß=0.26 (.14, .38) ß=0.30 (.19, .42)
Proportion Mediated by: 30.7%
Indirect Effect: ß=.08 (.04, .14)
FTND MNWS
11
Conclusions
• Addiction based barriers subscale is a significant mediator
between dependence and abstinence induced withdrawal
• Clinical implications
– Greater perceived addiction barriers, predict lower
cessation success rates
12
Future Directions
• Treatment seeking sample
• Sustained abstinence
• Larger number of European Americans
13
Acknowledgments
Raina D. Pang, PhD
Adam M. Leventhal, PhD
Matthew G. Kirkpatrick, PhD
Claudia Aguirre, BA
Mariel S. Bello, BS
Matthew D. Stone, BA
Health, Emotion & Addiction
Laboratory
14
Disclosure
Funding Sources
• National Institute on Drug
Abuse
– K01-DA040043
• American Cancer Society
– RSG-13-163-01
• Undergraduate Research
Associates Program, USC
15
Industry Funding
• N/A
Off-Label Medication Use
• N/A
Conflict of Interest Statement
• The authors report no conflicts
of interest

More Related Content

What's hot

3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance
Teleosis Institute
 
Assessing the Appropriateness of Oral Ketamine in Depression
Assessing the Appropriateness of Oral Ketamine in DepressionAssessing the Appropriateness of Oral Ketamine in Depression
Assessing the Appropriateness of Oral Ketamine in Depression
Michael Nguyen
 
Trajectories Poster last 3.20.15
Trajectories Poster last 3.20.15Trajectories Poster last 3.20.15
Trajectories Poster last 3.20.15
Michelle Aebi
 

What's hot (18)

Cytisine — A Tobacco Treatment Hiding in Plain Sight Nancy A. Rigotti, M.D. ...
Cytisine — A Tobacco Treatment Hiding in Plain Sight  Nancy A. Rigotti, M.D. ...Cytisine — A Tobacco Treatment Hiding in Plain Sight  Nancy A. Rigotti, M.D. ...
Cytisine — A Tobacco Treatment Hiding in Plain Sight Nancy A. Rigotti, M.D. ...
 
3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance
 
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
 
Relapse
RelapseRelapse
Relapse
 
Prevention Strategies For Dependency
Prevention Strategies For DependencyPrevention Strategies For Dependency
Prevention Strategies For Dependency
 
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
Responding to the Opioid Problem: New Directions in Research by Jack B. Stein...
 
Assessing the Appropriateness of Oral Ketamine in Depression
Assessing the Appropriateness of Oral Ketamine in DepressionAssessing the Appropriateness of Oral Ketamine in Depression
Assessing the Appropriateness of Oral Ketamine in Depression
 
Substance abuse and treatment final presentation
Substance abuse and treatment final presentationSubstance abuse and treatment final presentation
Substance abuse and treatment final presentation
 
Clinical review supporting smoking cessationqqqqqqq11111
Clinical review supporting smoking cessationqqqqqqq11111Clinical review supporting smoking cessationqqqqqqq11111
Clinical review supporting smoking cessationqqqqqqq11111
 
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...Preventing Prescription Opioid Overdoses: Changing Patients'  Risky Opioid Us...
Preventing Prescription Opioid Overdoses: Changing Patients' Risky Opioid Us...
 
Mdma (methylenedioxy methamphetamine) addiction hotline
Mdma (methylenedioxy methamphetamine) addiction hotlineMdma (methylenedioxy methamphetamine) addiction hotline
Mdma (methylenedioxy methamphetamine) addiction hotline
 
Addictive Behavior.pdf
Addictive Behavior.pdfAddictive Behavior.pdf
Addictive Behavior.pdf
 
Dr John Duffy Polypharmacy and Frailty
Dr John Duffy   Polypharmacy and FrailtyDr John Duffy   Polypharmacy and Frailty
Dr John Duffy Polypharmacy and Frailty
 
Trajectories Poster last 3.20.15
Trajectories Poster last 3.20.15Trajectories Poster last 3.20.15
Trajectories Poster last 3.20.15
 
Disparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSDisparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMS
 
Specialist Care and Primary Care Provider Performance 4.4.08
Specialist Care and Primary Care Provider Performance 4.4.08Specialist Care and Primary Care Provider Performance 4.4.08
Specialist Care and Primary Care Provider Performance 4.4.08
 
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
Non-medical Use and Medical Misuse of Opioids during Adolescence by Carol J B...
 
2 what works
2 what works2 what works
2 what works
 

Similar to SRNT Presentation

Mechanisms Underlying Mindfulness-Based Addiction Treatment
Mechanisms Underlying Mindfulness-Based Addiction Treatment Mechanisms Underlying Mindfulness-Based Addiction Treatment
Mechanisms Underlying Mindfulness-Based Addiction Treatment
AbramMartino96
 
Wilson compton nida
Wilson compton nidaWilson compton nida
Wilson compton nida
Donna Asbury
 
A Look at a Consumer Peer Based Program with Jill Williams, MD
A Look at a Consumer Peer Based Program with Jill Williams, MDA Look at a Consumer Peer Based Program with Jill Williams, MD
A Look at a Consumer Peer Based Program with Jill Williams, MD
sfary
 
Original ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docxOriginal ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docx
gerardkortney
 
Hani hamed dessoki biological addiction
Hani hamed dessoki biological addictionHani hamed dessoki biological addiction
Hani hamed dessoki biological addiction
Hani Hamed
 
Point of Care
Point of CarePoint of Care
Point of Care
growell
 
intro_to_addiction_merlo
intro_to_addiction_merlointro_to_addiction_merlo
intro_to_addiction_merlo
mmutahir
 

Similar to SRNT Presentation (20)

Screening, Brief Intervention and Referral to Treatment (SBIRT)
Screening, Brief Intervention and Referral to Treatment (SBIRT)Screening, Brief Intervention and Referral to Treatment (SBIRT)
Screening, Brief Intervention and Referral to Treatment (SBIRT)
 
Mechanisms Underlying Mindfulness-Based Addiction Treatment
Mechanisms Underlying Mindfulness-Based Addiction Treatment Mechanisms Underlying Mindfulness-Based Addiction Treatment
Mechanisms Underlying Mindfulness-Based Addiction Treatment
 
Drug Addiction Final pptx
Drug Addiction Final pptxDrug Addiction Final pptx
Drug Addiction Final pptx
 
Wilson compton nida
Wilson compton nidaWilson compton nida
Wilson compton nida
 
PROFESSOR JONATHAN CHICK - ANTIPATHY OR NAIVETY: 12-STEP FACILITATION IN UK H...
PROFESSOR JONATHAN CHICK - ANTIPATHY OR NAIVETY: 12-STEP FACILITATION IN UK H...PROFESSOR JONATHAN CHICK - ANTIPATHY OR NAIVETY: 12-STEP FACILITATION IN UK H...
PROFESSOR JONATHAN CHICK - ANTIPATHY OR NAIVETY: 12-STEP FACILITATION IN UK H...
 
Dr. Patricia Conrod - PreVenture [March 7 ADEPIS seminar]
Dr. Patricia Conrod - PreVenture [March 7 ADEPIS seminar]Dr. Patricia Conrod - PreVenture [March 7 ADEPIS seminar]
Dr. Patricia Conrod - PreVenture [March 7 ADEPIS seminar]
 
A Look at a Consumer Peer Based Program with Jill Williams, MD
A Look at a Consumer Peer Based Program with Jill Williams, MDA Look at a Consumer Peer Based Program with Jill Williams, MD
A Look at a Consumer Peer Based Program with Jill Williams, MD
 
Final Paper
Final PaperFinal Paper
Final Paper
 
AAAP conference Poster Finalized Nov. 25th (1)
AAAP conference Poster Finalized Nov. 25th (1)AAAP conference Poster Finalized Nov. 25th (1)
AAAP conference Poster Finalized Nov. 25th (1)
 
Non compliance
Non complianceNon compliance
Non compliance
 
Original ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docxOriginal ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docx
 
Seminar on Addiction and Substance use
Seminar on Addiction and Substance useSeminar on Addiction and Substance use
Seminar on Addiction and Substance use
 
Risks and Strategies Associated with Psychoactive Drugs Use and Young People
Risks and Strategies Associated with Psychoactive Drugs Use and Young PeopleRisks and Strategies Associated with Psychoactive Drugs Use and Young People
Risks and Strategies Associated with Psychoactive Drugs Use and Young People
 
Rethinking, rebuilding psychosocial care for cancer patients
Rethinking, rebuilding psychosocial care for cancer patientsRethinking, rebuilding psychosocial care for cancer patients
Rethinking, rebuilding psychosocial care for cancer patients
 
Substance use awarness
Substance use awarnessSubstance use awarness
Substance use awarness
 
Hani hamed dessoki biological addiction
Hani hamed dessoki biological addictionHani hamed dessoki biological addiction
Hani hamed dessoki biological addiction
 
The evidence base for mat
The evidence base for matThe evidence base for mat
The evidence base for mat
 
Point of Care
Point of CarePoint of Care
Point of Care
 
OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020OCD and Substance Use Disorder IOCDF Conference 2020
OCD and Substance Use Disorder IOCDF Conference 2020
 
intro_to_addiction_merlo
intro_to_addiction_merlointro_to_addiction_merlo
intro_to_addiction_merlo
 

SRNT Presentation

  • 1. Perceived Barriers to Smoking Cessation Mediates Tobacco Dependence and Withdrawal in a Primarily African American Sample Anika Suddath & Thomas Rutner Department of Preventive Medicine, USC 1
  • 2. Tobacco Related Race Disparities African Americans are affected disproportionately American Lung Association, 2010 Figure from NHIS data 2
  • 3. Dependence and Withdrawal • More heavily dependent smokers experience more severe withdrawal symptoms • Withdrawal Symptoms – anger, anxiety, craving, difficulty concentrating, hunger, impatience, and restlessness Shiffman (1989) Psycho Pharm Hughes et al., (1991) Arch Gen Psychiatry 3
  • 4. Withdrawal and Cessation Success • Severe withdrawal symptoms cause poorer cessation success rates • Previous cognitive mechanisms – Depression – Anxiety Patten and Martin (1996) Ann Behav Med 4
  • 5. Perceived Barriers Internal: “feeling less in control of your moods” External: “no encouragement or help from friends” Addiction: “thinking of never being able to smoke again” Perceived barriers predict smoking cessation rates Macnee & Talsma (1995) Nursing Research 5
  • 6. Hypothesis Perceived barriers to cessation act as a cognitive pathway to mediate the relationship between dependence and acute tobacco withdrawal Dependence Barriers Withdrawal 6
  • 7. Participants 249 daily smokers • non-treatment seeking • > 10 cig/day for past 2 years • no use of non-cigarette tobacco or nicotine products Age (SD) 47.2 (11.1) Sex 45.6% Female Race 90.4% African American Cigs/day 14.9 (6.6) Years Smoked 27.8 (12.1) Quit Attempts 4.6 (9.8) 7
  • 9. Measures Baseline Session • Fagerström Test of Nicotine Dependence (FTND) • Barriers to Cessation Scale (BCS) – Internal, External, & Addiction Subscales Experimental Sessions • Minnesota Nicotine Withdrawal Scale (MNWS) Hughes & Hatsukami, (1986) Gen Psychiatry Heatherton et al., (1991) Brit Jour Addict; Macnee & Talsma, (1995) Nurse Research; 9
  • 10. Statistical Analysis BCS Subscale Direct Effect A Path B Path Indirect Effect: A × B FTND MNWS 10 Hayes, (2012)
  • 11. BCS Addiction Mediational Pathway BCS Addiction ß=0.18 (.06, .29) ß=0.26 (.14, .38) ß=0.30 (.19, .42) Proportion Mediated by: 30.7% Indirect Effect: ß=.08 (.04, .14) FTND MNWS 11
  • 12. Conclusions • Addiction based barriers subscale is a significant mediator between dependence and abstinence induced withdrawal • Clinical implications – Greater perceived addiction barriers, predict lower cessation success rates 12
  • 13. Future Directions • Treatment seeking sample • Sustained abstinence • Larger number of European Americans 13
  • 14. Acknowledgments Raina D. Pang, PhD Adam M. Leventhal, PhD Matthew G. Kirkpatrick, PhD Claudia Aguirre, BA Mariel S. Bello, BS Matthew D. Stone, BA Health, Emotion & Addiction Laboratory 14
  • 15. Disclosure Funding Sources • National Institute on Drug Abuse – K01-DA040043 • American Cancer Society – RSG-13-163-01 • Undergraduate Research Associates Program, USC 15 Industry Funding • N/A Off-Label Medication Use • N/A Conflict of Interest Statement • The authors report no conflicts of interest

Editor's Notes

  1. I’m Thomas Rutner and we’re undergraduate fellows from the University of Southern California here to present our talk on the mediational affect of Perceived Barriers to Smoking cessation from tobacco Dependence to withdrawal in African Americans.   So let’s begin.
  2. In the 50 years since the original surgeon general report on its dangers, cigarette smoking has dropped drastically to about 20% of the adult population in the United States. However, smoking remains the leading cause of cancer and is the cause of nearly 400 thousand premature deaths annually. Many groups also remain disproportionately at risk. One of these is the African American population, which has been shown to have higher rates of lung cancer and lower successful cessation rates compared to other smoking populations. This graph comes from National Health Interview Survey which shows that African-Americans have consistently had lower successful cessation rates than both white and Hispanic populations since 1965. In addition, the population remains understudied in tobacco literature, which has led us to make this group be the focus of our study.
  3. Given the ubiquitous information regarding the danger of smoking, many highly dependent smokers express a desire to quit, but find themselves unable to do so. Previous studies have shown that more heavily dependent smokers experience more severe withdrawal symptoms. This is problematic because withdrawal symptoms have been shown to directly correlate to smokers having greater difficulty quitting. These symptoms which we measured include anger, anxiety, craving, difficulty concentrating, hunger, impatience, and restlessness.
  4. So as I mentioned, more severe symptoms have been shown to result in poorer cessation success, which leads a lot of study today being devoted to reducing these symptoms. The goal is that finding ways to reduce these symptoms may help the final 20% of the population quit smoking. With that in mind, our literature search showed that previous studies have considered how depression, anxiety, and other mental conditions can act as cognitive mechanisms to affect smoking cessation, but have yet to consider perceived barriers as one of these potential cognitive mechanisms.
  5. Anika Perceived barriers to cessation acts as a cognitive appraisal which underlies a smoker’s self confidence in quitting. It’s important to think of these barriers not as current obstacles in a smoker’s life; rather as perceived or possible obstacles which may hinder a smoker during a future cessation attempt. These obstacles fall into three distinct categories internal, external and addiction which are related to three distinct bodies of literature associated with smoking cessation. For example, if a smoker believes that feeling less in control of her mood would hinder her ability to quit, that would be an internal barrier. As an individual develops a higher dependency to tobacco, say they smoke a cigarette as soon as they wake up in the morning, with their cup of coffee, with every meal and with their friends, cigarettes become a more integral part of the smoker’s life, thus when thinking about a quit attempt a more highly dependent smoker may perceive no encouragement or help from their friends as a larger hindrance to a successful quit attempt. When compared to a less dependent smoker, let’s say someone who smokes once a week, not having that help or encouragement from their friends may not seem as big of an obstacle in their quit success. Interestingly, addiction based barriers such ast thinking of never being able to smoke again, or other pharmacological and behavioral withdrawal symptoms are some of the most commonly reported perceived barriers to quitting. Furthermore, perceived barriers have also been found to independently predict the success or relapse rate of a smoking cessation attempt.
  6. Anika While no study to our knowledge has investigated perceived barriers as cognitive mechanism between tobacco dependence and tobacco withdrawal, prior theory does supports this pathway. Therefore we hypothesize that perceived barriers to a cessation attempt act as a cognitive pathway to mediate the relationship between dependence and acute tobacco withdrawal
  7. Anika Our study includes 249 non-treatment seeking daily cigarette smokers In order to participate the participants must have been smoking 10 cigarettes a day or more for the past two year, be 18 years or older, fluent in English in order to complete our surveys, they could not have a current DSM_IV mood disorder or non-nicotine substance dependence, they could not use be using any other tobacco or nicotine products, and our female participants could not be currently pregnant or had a child within the past 6 months. The average age of our participants was 47 years old, about 46% were female. 90.4% were African American, our study is not comprised exclusively of African Americans because it is part of a larger ongoing study where we are collecting data for a control group comprised of European Americans, for our smoking statistics the average number of cigarettes smoked per day was 15, years smoked was 28, and lifetime quit attempts was 4.6.
  8. Anika In our study design, after an initial phone screening to determine their eligibility, participants were scheduled for their baseline session, which was followed by two experimental session that were randomized and counterbalanced. If a participant was in randomization scheme A they
  9. During the baseline or initial session we measured each smoker’s dependence and perceived barriers. To assess nicotine dependence severity we used the fagerstrom test of nicotine dependence which is a well-validated and widely used measure for this purpose. The barriers to cessation scale measures the degree to which perceived barriers may hinder the smoker during a future cessation attempt. The barriers are broken down into 3 subscales internal, external and addiction, where the participants must rate whether each item would be not a barrier to large barrier in hindering them during a future quit attempt. During each of the experimental sessions we used the minnesota nicotine withdrawal scale which measures withdrawal symptoms experienced so far today on a scale from none to severe. In our dataset we used the difference score between the non-deprived and deprived sessions to model abstinence induced withdrawal symptoms
  10. So for our statistical analysis we used Process Macro for SPSS as our mediational pathway. To do so we labeled an A path which is the path of the predictor to the mediator, in our case the from Nicotine Dependence to the Perceived Barriers, and then a B path from the mediator to the outcome while controlling for the predictor, so the Perceived Barriers to Withdrawal Symptoms. After doing this, the model determines the indirect or mediational effect by multiplying paths A and B. After running this model for all the subscales, we controlled for depression, anxiety, gender, and smoking statistics, and the only one that was significant was the BCS Addiction as a mediational pathway.
  11. So in this graphic to display our pathways we see we do have a significant direct path, which is the predictor to the outcome, or in our case FTND to the MNWS. But we also see that we have a significant A path and B path in order to end with a significant mediational effect. When we take this indirect effect and divide it by the total effect we see, we end up with a proportion mediated by of 30.7%. And so this shows that increased nicotine dependence predicts increased perceived addiction based barriers to cessation which in turn predicts more severe withdrawal symptoms during acute abstinence.
  12. Which leads us to our conclusion, once again, that addiction based barriers represent a significant mediator between tobacco dependence and withdrawal symptoms. By extension, this also shows that these barriers could affect a smoker’s ability to quit, which has a number of clinical implications for the future. There is potential for the use of this information in treatment programs which do not currently appraise their patients’ perceived barriers to smoking cessation. We hope that this may help the treatment programs reach the last, most treatment-resistant, group of smokers.
  13. The scope of our current study does lead to some future directions. We’re limited in our study to only include non-treatment seeking smokers and only being able to analyze the effect of acute abstinence of about 16 hours. Both of these traits make extrapolation from our findings to the overall smoking population difficult as treatment-seeking smokers or long-term abstinence effects may report differently. A future study may be able to examine these effects in a longitudinal study to even better inform treatment programs. As a final note, we did not have enough European American participants to make any conclusions between races and further study of this population would make these comparisons possible. However, the results are still promising and provide some clarity on how perceived barriers affect quit attempts in the smoking population at large, not just African-Americans.
  14. NIDA grant K01-DA040043